Literature DB >> 3198603

Purification of RNA polymerase IIO from calf thymus.

W Y Kim1, M E Dahmus.   

Abstract

Three subspecies of RNA polymerase II, designated IIO, IIA, and IIB, have been described in calf thymus and shown to differ in the apparent molecular weight of their largest subunits, designated IIo, IIa, and IIb, respectively. The objective of this study was to develop a procedure for the purification of RNA polymerase IIO. This form of the enzyme predominates in vivo and is responsible for the transcription of most cellular genes. RNA polymerase II is solubilized from isolated calf thymus nuclei in the presence of high concentrations of chelators, precipitated with polyethyleneimine, extracted with salt, and precipitated with (NH4)2SO4. The solubilized enzyme is resolved from factors that destabilize RNA polymerase IIO by chromatography on heparin-Sepharose CL-4B and DE52. RNA polymerase IIO is then partially resolved from RNA polymerases IIA and IIB by chromatography on DEAE-5PW and further purified by chromatography on Phenyl-Superose and Mono Q. RNA polymerase IIO was purified 1000-fold from the polyethyleneimine eluate resulting in about 130 micrograms of RNA polymerase IIO from 300 g of calf thymus. The specific activity of RNA polymerase IIO, in nonselective assays using calf thymus DNA as template, is 440 units/mg and not significantly different from that of RNA polymerases IIA and IIB. The similar transcriptional activities in nonselective assays suggest that the C-terminal domain of the largest RNA polymerase II subunit does not play a major role in the elongation phase of the reaction when deproteinized DNA serves as template. The small subunits of RNA polymerase IIO are indistinguishable from those of RNA polymerases IIA and IIB.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3198603

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  RNA Polymerase II Regulates Topoisomerase 1 Activity to Favor Efficient Transcription.

Authors:  Laura Baranello; Damian Wojtowicz; Kairong Cui; Ballachanda N Devaiah; Hye-Jung Chung; Ka Yim Chan-Salis; Rajarshi Guha; Kelli Wilson; Xiaohu Zhang; Hongliang Zhang; Jason Piotrowski; Craig J Thomas; Dinah S Singer; B Franklin Pugh; Yves Pommier; Teresa M Przytycka; Fedor Kouzine; Brian A Lewis; Keji Zhao; David Levens
Journal:  Cell       Date:  2016-04-07       Impact factor: 41.582

2.  Heat-shock inactivation of the TFIIH-associated kinase and change in the phosphorylation sites on the C-terminal domain of RNA polymerase II.

Authors:  M F Dubois; M Vincent; M Vigneron; J Adamczewski; J M Egly; O Bensaude
Journal:  Nucleic Acids Res       Date:  1997-02-15       Impact factor: 16.971

3.  A protein kinase from wheat germ that phosphorylates the largest subunit of RNA polymerase II.

Authors:  T J Guilfoyle
Journal:  Plant Cell       Date:  1989-08       Impact factor: 11.277

4.  RNA polymerase II is aberrantly phosphorylated and localized to viral replication compartments following herpes simplex virus infection.

Authors:  S A Rice; M C Long; V Lam; C A Spencer
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

5.  RNA polymerase II cofactor PC2 facilitates activation of transcription by GAL4-AH in vitro.

Authors:  M Kretzschmar; G Stelzer; R G Roeder; M Meisterernst
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

6.  Opening of an RNA polymerase II promoter occurs in two distinct steps and requires the basal transcription factors IIE and IIH.

Authors:  F C Holstege; P C van der Vliet; H T Timmers
Journal:  EMBO J       Date:  1996-04-01       Impact factor: 11.598

7.  Repression of basal transcription by HMG2 is counteracted by TFIIH-associated factors in an ATP-dependent process.

Authors:  G Stelzer; A Goppelt; F Lottspeich; M Meisterernst
Journal:  Mol Cell Biol       Date:  1994-07       Impact factor: 4.272

8.  Autoantibodies to RNA polymerase II are common in systemic lupus erythematosus and overlap syndrome. Specific recognition of the phosphorylated (IIO) form by a subset of human sera.

Authors:  M Satoh; A K Ajmani; T Ogasawara; J J Langdon; M Hirakata; J Wang; W H Reeves
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

9.  Genetic interactions of Spt4-Spt5 and TFIIS with the RNA polymerase II CTD and CTD modifying enzymes in Saccharomyces cerevisiae.

Authors:  D L Lindstrom; G A Hartzog
Journal:  Genetics       Date:  2001-10       Impact factor: 4.562

10.  Tyrosine phosphorylation of mammalian RNA polymerase II carboxyl-terminal domain.

Authors:  R Baskaran; M E Dahmus; J Y Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.